https://scholars.duke.edu/publication/1264906
Scholars@Duke publication: ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC...
https://meyercancer.weill.cornell.edu/news/2017-08-30/impact-fda-approval-ctl019-all
Impact of the FDA Approval of CTL019 in ALL | Sandra and Edward Meyer Cancer Center
Gail J. Roboz, M.D., discusses the impact of the FDA approval of tisagenlecleucel (CTL019; Kymriah) in select pediatric and young adult patients with a form of...